Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.05 USD | +9.37% | +33.76% | +61.09% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.09% | 2.59B | |
+73.10% | 12.38B | |
-19.92% | 7.81B | |
+8.05% | 6.72B | |
+12.49% | 5.39B | |
+40.80% | 5.03B | |
-18.12% | 4.72B | |
-22.01% | 4.06B | |
-28.94% | 2.68B | |
0.00% | 1.96B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited, Q1 2024 Earnings Call, May 02, 2024